About

About LaCAR MDx Technologies LACAR is a biotech company specializing in rapid "sample-to-result" diagnostic solutions for pharmacogenetics. Our kits are designed to simplify laboratory workflows and speed up TAT for patient safety. Our organization operates from Durham, NC RTP across all the United States. Our primary mission at AACR 2026 is to showcase how we are securing the patient journey by making pharmacogenetic testing a seamless clinical routine. We will feature our DPYD 7-variant genetic test, which utilizes proprietary technology to deliver results in under an hour without the need for DNA extraction. This "US-ready" panel meets AMP Tier 1 recommendations and covers variants critical for diverse populations, including those of African descent. This provides clinicians with an immediate solution to meet the latest FDA safety standards for fluoropyrimidine treatments.